Open AccessP953: PHASE I STUDY OF TQB3602 CAPSULE, AN ORAL PROTEASOME INHIBITOR, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
Author(s) -
Tang W.,
Li Y.,
Zhong X.,
Liang Q.,
Liu Y.,
Zeng Y.,
Fang B.,
Zheng L.,
Niu T.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846680.89917.3a
Subject(s) - ixazomib , lenalidomide , medicine , proteasome inhibitor , bortezomib , pharmacology , multiple myeloma , thalidomide , toxicity , oncology , gastroenterology , carfilzomib